Biodesix Inc (BDSX)
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Last price
- $22.86
- As of
Kresmion compiles this page from BDSX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
BIODESIX INC (BDSX): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-05.
See the full BDSX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for BDSX on one page. Preview it with sample data, then open it live with a free account.
Preview the BDSX dossierActive events for BDSX
- mediumEarnings above estimates
Q2-2026: Beat consensus by 22.9%, EPS $-0.71 vs $-0.9203 estimate
- high13F: large increase
RENAISSANCE TECHNOLOGIES LLC added +140% to BDSX (2026Q2)
- high13F: large increase
TWO SIGMA INVESTMENTS, LP added +92% to BDSX (2026Q2)
- high13F: funds added
3 tracked funds increased BDSX this 2026Q1 - institutional consensus
- high13F: large increase
MILLENNIUM MANAGEMENT LLC added +61% to BDSX (2026Q1)
FREE, NO ACCOUNT
Every event on BDSX, as it fires
You are seeing 5 of 11 events recorded on BDSX since 2026-06-12.
The five above landed across 2 days. The other 6 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in BDSX (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LPCUSIP 09075X207 · 2026Q2 | $2M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 09075X207 · 2026Q2 | $646K | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 09075X207 · 2026Q2 | $325K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, BDSX
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
BDSX against its peers
BDSX's operating margin of -31.5% ranks in the 45th percentile of 18 Diagnostics & Research sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-06-30.
| Metric | BDSX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 88.5M USD | 77.2M USD | 53 | 19 |
| Gross margin | n/a | 62.2% | n/a | 14 |
| Operating margin | -31.5% | -17.6% | 45 | 18 |
| Net margin | -39.8% | -14.9% | 28 | 19 |
| Return on equity | n/a | -7.0% | n/a | 17 |
Peers (21): BNR, FONR.D, IMDX, QUCY, OPK, PRPO, IDXG, PSNL, MBAI, NEO, MDXH, LDDD, CDNA, BLLN, XWEL, NDRA, AWHL, ADVB, QGEN, TWST, ICLR. Left out: ANPCF (no annual filing), PMDI (period gap), BIAF (no annual filing), NOTV.D (no annual filing). Fiscal periods ending between 2025-06-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (BDSX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow BDSX on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to BDSX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.